| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 01/08/1997 | EP0751991A1 Protease enzyme manufacture using non-protein protease inhibitors |
| 01/08/1997 | EP0751990A1 Detergent compositions |
| 01/08/1997 | EP0751989A1 Isoenzyme calibrator/control products |
| 01/08/1997 | EP0751984A1 Detergent compositions |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751951A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 01/08/1997 | EP0751948A1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 01/08/1997 | EP0751786A1 Urease-based vaccine and treatment for helicobacter infection |
| 01/08/1997 | EP0706320B1 Method of controlling insects |
| 01/08/1997 | EP0651814B1 Maize pollen-specific polygalacturonase gene |
| 01/08/1997 | EP0497828B1 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 01/08/1997 | CN1139956A Process for producing substance |
| 01/07/1997 | US5591839 Polynucleotides encoding α2-3 neuraminidase |
| 01/07/1997 | US5591772 Dietary supplements |
| 01/07/1997 | US5591720 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/07/1997 | US5591639 Plasmids and gene expression for dna sequences |
| 01/07/1997 | US5591620 Methods of detecting and isolating a ripening form of a polypeptide having rhamnogalacturonase activity |
| 01/07/1997 | US5591619 Genetic engineering |
| 01/07/1997 | US5591618 G protein-coupled receptor kinase GRK6 |
| 01/07/1997 | US5591615 Mutant of Geotrichum candidum which produces novel enzyme system to selectively hydrolyze triglycerides |
| 01/07/1997 | US5591612 Trehalose-releasing enzyme, and its preparation and uses |
| 01/07/1997 | US5591611 Enzyme which hydrolyzes trehalose end group from remaining partial starch hydrolyzate |
| 01/07/1997 | US5591610 Dephosphorylation by ester interchange; genetic engineering |
| 01/07/1997 | US5591604 Recombinant antibodies at the surface of E. coli |
| 01/07/1997 | US5591601 DNA polymerase gene expression system utilizing an RNA polymerase co-delivered with the gene expression vector system |
| 01/07/1997 | US5591576 Sterol Δ14 reductase screen |
| 01/07/1997 | CA2115136C Factor xiii compositions |
| 01/07/1997 | CA2079585C Ligand for the neu gene product |
| 01/07/1997 | CA1338829C Superior mammalian expression system |
| 01/07/1997 | CA1338827C Fruit-specific transcriptional factors |
| 01/03/1997 | WO1997000324A1 Gene encoding alkaline liquefying alpha-amylase |
| 01/03/1997 | WO1997000316A1 A process for producing trypsin (trypsinogen) |
| 01/03/1997 | WO1997000315A1 MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASE cDNAs AND THEIR BIOLOGICALLY ACTIVE EXPRESSION PRODUCTS |
| 01/03/1997 | WO1997000077A1 Anti-metastatic and anti-angiogenic pharmaceutical compositions |
| 01/03/1997 | WO1996035717A3 Soluble, cleavable substrates of the hepatitis c virus protease |
| 01/03/1997 | CA2224560A1 Anti-metastatic and anti-angiogenic pharmaceutical compositions |
| 01/02/1997 | EP0751222A2 Gene encoding endoglycoceramidase |
| 01/02/1997 | EP0751218A2 Sucrose-metabolism mutants |
| 01/02/1997 | EP0751217A2 Enhancing keratinocyte migration with clostridiopeptidase-A-collagenase |
| 01/02/1997 | EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof |
| 01/02/1997 | EP0750673A1 Transgenic production of oligosaccharides and glycoconjugates |
| 01/02/1997 | EP0750672A1 Dna sequences for matrix metalloproteases, their production and use |
| 01/02/1997 | EP0750671A1 Transgenic animals producing oligosaccharides and glycoconjugates |
| 01/02/1997 | EP0750667A1 Use of a recombinant inhibitor from erythrina caffra for purifying serine proteases |
| 01/02/1997 | EP0750631A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 01/02/1997 | EP0750630A1 Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains |
| 01/02/1997 | EP0750627A1 Transgenic animal assay system for anti-cholinesterase substances |
| 01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin |
| 01/02/1997 | EP0750511A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 01/02/1997 | EP0750507A1 PROTEASOME REGULATION OF NF-$g(k)B ACTIVITY |
| 01/02/1997 | EP0750503A1 Ribozyme therapy for restenosis |
| 01/02/1997 | EP0750457A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |
| 01/02/1997 | EP0654082A4 CLONING AND EXPRESSION OF A HUMAN -g(a)(1,3)FUCOSYLTRANSFERASE, FUCT-VI. |
| 01/02/1997 | EP0654081B1 Hypoglycosylated recombinant glucosidase oxidases |
| 01/02/1997 | EP0556345B1 Retroviral vectors useful for gene therapy |
| 01/02/1997 | EP0552178B1 Modified ribozymes |
| 01/02/1997 | DE19525282A1 Yarrowia lipolytica expression cassette contg. ICL1 promoter and terminator |
| 01/02/1997 | DE19523660A1 Antigens with characteristics of retro-virus |
| 01/01/1997 | CN1139457A Aspergillus expression system |
| 01/01/1997 | CN1139456A Aspergillus foetidus expression system |
| 01/01/1997 | CN1139455A Thrombin mutants |
| 12/31/1996 | US5589626 Introducing into the genome a chimeric gene fusion of the tr promoter, the signal peptide sequence of barley alpha-amylase |
| 12/31/1996 | US5589625 Transgenic plants displaying multiple virus resistance and a process for their production |
| 12/31/1996 | US5589623 Transforming plant cells with a vector containing a dna sequence encoding an s-adenosylmethionine hydrolase enzyme |
| 12/31/1996 | US5589621 Transformed plant cell |
| 12/31/1996 | US5589620 Isolated from plants; useful in transforming vectors, host organisms and plants; produce plants which exhibit an increased resistance towards pests |
| 12/31/1996 | US5589619 Increasing the amount of a gene encoding a polypeptide having hmg-coa reductase activity |
| 12/31/1996 | US5589618 Polynucleotide |
| 12/31/1996 | US5589614 Plant-derived glutathione-S-transferase isoform II promoter |
| 12/31/1996 | US5589612 Genetic engineering |
| 12/31/1996 | US5589611 Disease resistance gene from maize and its use for disease resistance as a selectable marker and as a gene identification probe |
| 12/31/1996 | US5589604 Expression of human protein C in mammary tissue of transgenic mammals |
| 12/31/1996 | US5589581 DNA sequences useful for the synthesis of carotenoids |
| 12/31/1996 | US5589579 Gene sequence and probe for a marker of non-small cell lung carinoma |
| 12/31/1996 | US5589572 Process for production of inhibited forms of activated blood factors |
| 12/31/1996 | US5589571 Process for production of inhibited forms of activated blood factors |
| 12/31/1996 | US5589466 Induction of a protective immune response in a mammal by injecting a DNA sequence |
| 12/31/1996 | US5589386 Hydrolysis of cholinesterase inhibitors using parathion hydrolase |
| 12/31/1996 | US5589383 Protease deletion |
| 12/31/1996 | US5589379 Geminivirus-based gene expression system |
| 12/31/1996 | US5589375 Dephosphorylation |
| 12/31/1996 | US5589374 Diabetogene rad: a type II diabetes specific gene |
| 12/31/1996 | US5589373 Thermostable alkaline metalloprotease produced by a hyphomonas and preparation thereof |
| 12/31/1996 | US5589372 Squalene synthetase |
| 12/31/1996 | US5589371 Polypeptides and yeast expression vectors for culture |
| 12/31/1996 | US5589367 Recombinant plant viral nucleic acids |
| 12/31/1996 | US5589361 Human tissue-type plasminogen activator variant |
| 12/31/1996 | US5589354 Halogenation of cephalexin with haloperoxidase from Rathayibacter biopuresis |
| 12/31/1996 | US5589331 Method for detecting abnormal serotonergic function |
| 12/31/1996 | US5589170 Antiinflammatory agent |
| 12/31/1996 | CA2180280A1 Adenyl-cyclase-hemolysin (ac-hly)-protecting epitopes; use thereof for the treatment or the prevention of infections by bordetella |
| 12/31/1996 | CA2180202A1 Method of amplifying gene using artificial transposon |
| 12/31/1996 | CA2019745C Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
| 12/30/1996 | CA2180319A1 Modified bacterial alkaline phosphatases and use thereof |
| 12/29/1996 | CA2179439A1 Sucrose metabolism mutants |
| 12/27/1996 | WO1996041888A1 Yeast strains having a modified alcoholic sugar fermentation balance, uses thereof, and vectors for producing said strains |
| 12/27/1996 | WO1996041887A1 Dnase-active protein |
| 12/27/1996 | WO1996041886A1 Process to increase the production of clavam antibiotics |
| 12/27/1996 | WO1996041885A1 Expression of human inducible nitric oxide synthase |
| 12/27/1996 | WO1996041883A1 Plasmin-resistant streptokinase |